H3B-6527

≥98%

  • Product Code: 100776
  CAS:    1702259-66-2
Molecular Weight: 629.54 g./mol Molecular Formula: C₂₉H₃₄Cl₂N₈O₄
EC Number: MDL Number:
Melting Point: Boiling Point:
Density: Storage Condition: 2-8℃
Product Description: H3B-6527 is a selective inhibitor of fibroblast growth factor receptor 4 (FGFR4), which plays a significant role in certain cancers, particularly hepatocellular carcinoma (HCC). Its primary application is in cancer research and therapy, specifically targeting tumors that are driven by FGFR4 signaling. By inhibiting FGFR4, H3B-6527 can potentially reduce tumor growth and proliferation, making it a promising candidate for treating HCC and other FGFR4-dependent cancers. It is also used in preclinical studies to better understand the role of FGFR4 in cancer biology and to evaluate its efficacy as a targeted therapeutic agent.
Product Specification:
Test Specification
Appearance White Solid
Purity (%) 97.5-100
Infrared Spectrum Conforms To Structure
NMR Conforms To Structure
Sizes / Availability / Pricing:
Size (g) Availability Price Quantity
0.001 10-20 days €155.39
+
-
0.005 10-20 days €523.68
+
-
H3B-6527
H3B-6527 is a selective inhibitor of fibroblast growth factor receptor 4 (FGFR4), which plays a significant role in certain cancers, particularly hepatocellular carcinoma (HCC). Its primary application is in cancer research and therapy, specifically targeting tumors that are driven by FGFR4 signaling. By inhibiting FGFR4, H3B-6527 can potentially reduce tumor growth and proliferation, making it a promising candidate for treating HCC and other FGFR4-dependent cancers. It is also used in preclinical studies to better understand the role of FGFR4 in cancer biology and to evaluate its efficacy as a targeted therapeutic agent.
Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Cart

No products

Subtotal: €0.00
€0.00 Total :